25-Nov-2015 - As CMOs wait to see the short-term fallout of the Pfizer-Allergan deal, an M&A expert says contract manufacturing will follow the CRO industry in embracing strategic alliances and consolidation....
25-Nov-2015 - Restarting production at the former Ben Venue facility in Ohio will be a “significant task” says Xellia Pharmaceuticals which plans to invest after buying the site from Hikma.
23-Nov-2015 - US Customs and Border Protection (CBP) says the country of origin of Carlsbad Technology’s acyclovir is where the API is sourced, not the US where the tablets are made.
23-Nov-2015 - Juniper Pharmaceuticals has made a “significant capital investment” to expand its Xcelodose powder micro-dosing system to feed demand for Phase I study materials.
17-Nov-2015 - Cell Therapy Catapult, the UK fund for gene therapy, broke ground yesterday on a £55m bio-manufacturing centre in Stevenage, UK.
17-Nov-2015 - Out-of-place softgel capsules have led to the suspension of manufacturing at a site in France, and Catalent says the problem is almost certainly due to malicious actions.
16-Nov-2015 - Roche’s exit from four small molecule manufacturing plants will provide opportunities for third-party manufacturers, the firm says.
12-Nov-2015 - More than one hundred women are suing a subsidiary of Irish manufacturer Endo International, claiming a packaging error caused their contraception to fail and result in unwanted pregnancies.
10-Nov-2015 - CDMO Recipharm has signed a €25m ($26.7m) contract to supply API for Korean multinational Daewoong to make and market the respiratory drug Erdosteine.
09-Nov-2015 - CDMO Almac says it will hire 180 people following a £16m ($24m) expansion of formulation and analytical services.
09-Nov-2015 - Dr Reddy’s shares have slumped 14% after the company received an FDA Warning Letter over manufacturing conditions at three Indian sites.
09-Nov-2015 - AMRI attributed recent M&A activity to passing the $100m (€93m) quarterly sales milestone, reporting high double-digit growth across its API and small-scale manufacturing divisions.
05-Nov-2015 - Gaining a foothold in North America would complete Recipharm’s growth strategy in becoming a global CDMO leader, the firm says.
05-Nov-2015 - CMO consolidation strategy has shifted from building scale and adding geographies towards niche technologies and biologics, according to the founder of trade association PBOA.
04-Nov-2015 - While pharma is increasing use of automation and data integration tools in process development and manufacturing, it lags behind in electronic documentation of quality control, according to Lonza Biologics QC...
04-Nov-2015 - Almac has acquired Arran Chemical Company to further grow its biocatalysis services and increase its large-scale intermediates capacity.
03-Nov-2015 - Alexion says it is looking to bring more manufacturing capabilities in-house, despite its CMO partner Lonza recently setting up a dedicated suite at a site in New Hampshire.
22-Oct-2015 - As pharma sells off manufacturing capacity and outsources to large and specialist CMOs, smart contract houses will have an opportunity to grab market share in a currently fragmented sector, say...
20-Oct-2015 - The US FDA has issued an alert warning the public not to take drugs marked as sterile by compounding firm Qualgen.
20-Oct-2015 - An agreement to buy Indian CMO Nitin boosts Recipharm’s presence in emerging markets and plays into its aggressive growth strategy, the firm says.
20-Oct-2015 - Hovione will spend $10m refurbishing a plant acquired from a Portuguese generics company to create an oral and inhalation formulation site.
19-Oct-2015 - Pharma is looking to condense the number of contract manufacturers it works with, says Aesica which has launched a service to help manage its customers’ supply chain.
19-Oct-2015 - An Irish compounding pharmacy has recalled several batches of chemotherapy medicines because of a sterility alert.
16-Oct-2015 - CDMO Ajinomoto Althea is opening a new facility to offer outsourced ADC (antibody drug conjugate) and HPAPI (highly potent active pharmaceutical ingredient) manufacturing, the Californian company has announced.
15-Oct-2015 - Big Pharma has returned to Europe for its API sourcing due to reasons of quality and reliability, according to the European Fine Chemicals Group (EFCG).